A bedrock of the U.S. mental health system — a 9-item questionnaire used to spot depression — began not with a doctor, but with a marketer.
In the aftermath of Ohio's train disaster, concerns are mounting about potential chemical exposures sustained by humans and wildlife.
Hong Kong pulled the visa for He Jiankui hours after he announced his research plans in the financial hub.
The companies behind America’s favorite culinary indulgences are upset their foods wouldn’t be “healthy” under a recent FDA proposal.
The antibody-radiation treatment, called Iomab-B, is being developed by Actinium Pharmaceuticals, a small drugmaker based in New York.
Big Tobacco's "harm reduction" seems to be marketing nicotine-laden vaping products and lobbying against regulating traditional cigarettes.
